New drug targets Hard-to-Treat uterine cancer in small trial
Disease control
Recruiting now
This study tests a drug called enfortumab vedotin in up to 12 people with advanced endometrial (uterine) cancer that has worsened after standard treatments like immunotherapy. The drug works by targeting a protein on cancer cells to kill them. Researchers will measure how many pa…
Phase: PHASE2 • Sponsor: William Bradley • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC